Remove 2024 Remove Compliance Remove Health Services Administration Remove Public Health
article thumbnail

DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE

Hall Render

As a result, if a patient and a practitioner have appropriately established a telemedicine relationship on or before November 11, 2023, the same telemedicine flexibilities that have governed the relationship to that point will continue to be permitted until November 11, 2024.

article thumbnail

HHS Announces 42 Part 2 Final Rule to Align with HIPAA

Healthcare Law Blog

Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) recently released the long anticipated Final Rule to revise the Confidentiality of Substance Use Disorder (SUD) Patient Records regulations at 42 C.F.R. 2] Public Health Authority Disclosure.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bonus Features – May 14, 2023 – Only 16% of organizations are using data to define clinical best practices, 84% of orgs hit with ransomware attacks lose revenue, and more

Healthcare IT Today

News In a temporary rule, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) extended telemedicine flexibilities for prescribing controlled medications for six months following the end of the public health emergency, through November 11.

article thumbnail

HIPAA Updates and HIPAA Changes in 2023

HIPAA Journal

Such major HIPAA updates placed a significant burden on HIPAA-covered entities and considerable time and effort were required to introduce new policies and procedures to ensure continued HIPAA compliance. What is certain is HIPAA officers and other compliance staff will have a busy few months when the Final Rule is published.

HIPAA 107
article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

Notably, the Act neither fulfilled the Biden Administration’s request for additional COVID-19 response funding nor included the Verifying Accurate Leading-edge In Vitro Clinical Test (IVCT) Development (VALID) Act, which proposed updating the current diagnostic testing regulatory framework.

Medicaid 104